MarkApplebaumMD

PubMed

• Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity.
  Yan-Hong Cui, Jiangbo Wei, Hao Fan, Wenlong Li, Lijie Zhao
  Proceedings of the National Academy of Sciences of the United States of America. 2024-12-17
• Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology.
  Siddhi Ramesh, Emma Dyer, Monica Pomaville, Kristina Doytcheva, James Dolezal
  NPJ Precision Oncology. 2024-11-08
• Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures.
  Maria E Kaufman, Omar R Vayani, Kelley Moore, Alexandre Chlenski, Tong Wu
  Cancer Research Communications. 2024-08-01

Journal Articles

• Case Report Second Primary Rhabdomyosarcoma of the Uterine Cervix Presenting with Synchronous Ovarian Sertoli-Leydig Cell Tumor: An Illustrative Case of DICER1 Syndrome  
  Matthew Cowan, Melody Perpich, Mark A Applebaum, S Diane Yamada, Andrea D Olivas, Ricardo R Lastra, ScienceDirect
• Evaluation of genetic predisposition for MYCN-amplified neuroblastoma  
  Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Diskin SJ, Maris JM, Onel K, Cohn SL, J Natl Cancer Inst, 1/1/2017

Books/Book Chapters

• Transition from pediatric to adult medical care 
  Chapter: Utilization of technology in transition programs 
  Applebaum MA, Lawson EF, von Scheven EEditors: Wood D, Reiss JG, et al.Nova Science, New York, NY2012

Abstracts/Posters

• Second Malignancies in Patients with Neuroblastoma
  Applebaum MA, International Neuroblastoma Conference, Houston, TX, 1/1/2017
• Whole Genome Analysis of the Epigenetic Mark 5-Hydroxymethylcysteine Reveals Differential Profiles in Low-, Intermediate-, and High-Risk Neuroblastoma
  Applebaum MA, AACR Conference on Pediatric Cancer Research, Atlanta, GA, 1/1/2017
• Evaluation of Hypoxia Adaptation in Neuroblastoma Identifies Reproducible Transcriptional and Phenotypic Ressponses
  Applebaum MA, ASCPT Annual Meeting, San Diego, CA, 1/1/2016
• Advances in treatment of pediatric bone sarcomas
  Applebaum MA, University of Chicago Comprehensive Cancer Center translational seminar series, 1/1/2016
• Integrative genomics reveals hypoxia inducible genes that confer a poor prognosis in neuroblastoma patients
  Applebaum MA, Pediatric Research Da, Univeristy of Chicago. Chicago, IL, 1/1/2016
• Genetic Variants in BARD1 and KIF15 are Associated with MYCN-Amplification in Neuroblastoma
  Applebaum MA, Advances in Neuroblastoma Research Congress, Cairns, Australia, 1/1/2016
• Second Malignancies in Patients with Neuroblastoma: A Report from the International Neuroblastoma Risk Group Project
  Applebaum MA, Advances in Neuroblastoma Research Congress, Cairns, Australia, 1/1/2016
• Genetic Variants in KIF15 are Associated with MYCN-Amplification in Neuroblastoma
  Applebaum MA, Children�s Oncology Group Annual Meeting, Atlanta, GA, 1/1/2016
• Ototoxicity in Pediatric Oncology
  Applebaum MA, Audiology Symposium: Applied Practices in Audiology, Chicago, IL, 1/1/2016
• Second malignancies in neuroblastoma patients: A report from the International Neuroblastoma Risk Group
  Applebaum MA, ASCO Annual Meeting, Chicago, IL, 1/1/2015
• Identification of gene expression patterns that confer an aggressive neuroblastoma phenotype
  Applebaum MA, Third Annual Meeting of T32 Trainees, Rockford, MD, 1/1/2014
• Identification of conserved hypoxia-induced genomic pathways that drive�aggressive neuroblastoma phenotypes
  Applebaum MA, Pediatric Fellow Research Symposiu, University of Chicago, Chicago, IL, 1/1/2014
• Join now to see all

Other

• B-LL, BCR-ABL-like 
  Venkataraman G, Ritterhouse L, Segal J, Applebaum M, Suntum T, Sukhanova M, American Society of Hematology Image Bank
  https://imagebank.hematology.org/reference-case/65/ball-blasts-in-blood
  1/1/2018